InvestorsHub Logo
Followers 81
Posts 12054
Boards Moderated 0
Alias Born 05/30/2009

Re: None

Thursday, 07/20/2017 1:02:35 PM

Thursday, July 20, 2017 1:02:35 PM

Post# of 3853
INTIVA BioPharma Inc. has filed a provisional patent application with the United States Patent Office describing methods and compositions for improving sexual health. The methods comprise the administration of a composition comprising one or more cannabinoids and/or one or more terpenes.

Sexual health is a major topic of discussion and research because it affects both males and females. Sexual health issues, sometimes termed sexual dysfunction, may be the result of organic issues, psychological issues or a combination of both.

Examples of organic issues include vascular diseases, such as those associated with hypertension or diabetes mellitus, prescription medication, and/or by psychiatric disease such as depression.

Examples of psychological factors include fear, performance anxiety, and interpersonal conflict. Sexual health issues and sexual dysfunction issues, in particular, may impair sexual performance, diminish self-esteem and disrupt personal relationships thereby inducing personal distress.

Male sexual health issues or dysfunction issues include male erectile dysfunction, ejaculatory disorders, such as premature ejaculation, anorgasmia (inability to achieve orgasm) and desire disorders such as hypoactive sexual desire disorder (lack of interest in sex).

Female sexual health issues or dysfunction issues include genitopelvic pain/penetration disorders, sexual interest/arousal disorders, and female orgasmic disorders.

Robert Goldfarb, COO of INTIVA BioPharma, stated, “Due to the scope of male and female health issues, there is a need for improvements in the treatments.” He further stated, “For both men and women anecdotal evidence suggests benefits in using cannabinoids and/or terpenes for improving sexual health. We’re hopeful that our pre-clinical and clinical pathway will lead to one or more medicines that improve conditions affecting male and female sexual health.”

INTIVA BioPharma has assembled a team of experienced professionals in pharmaceutical development and regulatory compliance for its drug development activities
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NXEN News